Skip to content

We don't sell Iboga

Iboga .co
  • Home
  • The substance

    The plant Science Safety

    Treatment

    Treatment Legality Compare

    Context

    Tradition Experiences News
  • About
  • Contact
Become a contributor All articles

Professor and vice chair of pharmacology and toxicology at the University of Texas Medical Branch, Chauncey Leake Distinguished Professor of Pharmacology, and director of the Center for Addiction Sciences and Therapeutics. A behavioural neuropharmacologist by training, she works on the receptor pharmacology of substance use disorder and on turning that work into candidate treatments, which is the ground the pharmacology and addiction pages on this site stand on. Disclosure: UTMB Health is a partner in the public-university consortium awarded $50 million by the State of Texas in December 2025 to run ibogaine clinical trials, a programme this site covers.

Scientific review

  • Iboga Compared
  • Ibogaine Science and Research
  • Iboga vs Ibogaine: The Difference
  • Ibogaine vs Ayahuasca
  • Ibogaine vs Bufo
  • Is Ibogaine Like DMT?
  • Ibogaine vs Kambo
  • Ibogaine vs Psilocybin
  • Ibogaine vs Ketamine
  • Microdosing Iboga: What We Know
  • Iboga Visuals: What People Actually See
  • Who Is Developing Ibogaine, and What They Have Delivered
  • Ibogamine and the Other Alkaloids of Iboga
  • Iboga Root Bark
  • Ibogaine and Bipolar Disorder
  • "Ibogaine Detox": What the Term Hides
  • Ibogaine Dosage: Why There Is No Standard Dose
  • Ibogaine Drug Interactions
  • 18-MC: The Analogue Built to Drop the Cardiac Risk
  • Ibogaine Analogues: What Exists, and What Reached People
  • Where Iboga Alkaloids Act in the Brain
  • Ibogaine Clinical Trials: What Has Actually Been Run
  • CYP2D6: Why Response Varies Between People
  • GDNF and BDNF: What the Growth Factor Claim Rests On
  • How Ibogaine Works
  • Ibogaine for Alcoholism
  • Ibogaine for Depression and Anxiety
  • Ibogaine for Peripheral Neuropathy and CIDP
  • Ibogaine for Opioid Addiction: What the Evidence Shows
  • Ibogaine for Parkinson's and MS
  • Ibogaine for PTSD: One Cohort, Six Papers
  • Noribogaine: The Metabolite That Outlasts the Drug
  • Ibogaine for Other Addictions: Cocaine, Nicotine and Beyond
  • Ibogaine Success Rate: Why There Isn't One
  • Tabernanthalog: Sold by the Kilogram, Never Given to a Human
  • What Science Doesn't Know Yet
  • What Ibogaine Is
  • After Treatment: Integration and Relapse
  • Ibogaine Treatment in Canada
  • Where to Get Ibogaine Treatment: The Legal Map
  • Ibogaine Treatment in Florida
  • Ibogaine Treatment in New Zealand
  • Ibogaine in Oregon: The Bill That Did Not Pass
  • Ibogaine Treatment in South Africa
  • Ibogaine Therapy Explained
  • Ibogaine Treatment in Tijuana
  • Ibogaine Treatment in the United States
KA

Kathryn A. Cunningham

Scientific reviewer

PhD

Verifiable profiles

  • utmb.edu
  • researchexperts.utmb.edu
  • utmb.edu
  1. Home
  2. Contributors
  3. Kathryn A. Cunningham

iboga.co uses cookies strictly necessary for the operation of its website, as well as other cookies and tracking tools to measure the performance of its website and, with your agreement, to allow advertising partners to show you relevant advertisements on Facebook and Instagram after your visit. You can click "Accept all" to consent to the uses mentioned above, or click "Decline all" to refuse all optional cookies. Strictly necessary cookies do not require your consent and remain active at all times. You can change your preferences, and in particular withdraw your consent, at any time from our cookie policy. Until you accept, no measurement or advertising cookie is loaded.

Iboga .co

Independent information on iboga and ibogaine: the plant, the science, the risks, the law, and the Bwiti tradition it comes from.

Sections

  • The plant
  • Science
  • Safety
  • Legality
  • Treatment

More sections

  • Tradition
  • Experiences
  • Compare
  • News

About this site

  • The complete guide
  • All articles
  • About
  • Editorial policy
  • Medical review
  • How we source
  • Contributors
  • Contact
iboga.co

© 2026 iboga.co. Independent and unaffiliated.